Answers are grounded in this paper and cite their sources.
Selective inhibition of adenylation domains of nonribosomal peptide synthetases can be developed from aminoacyl adenosine derivatives. The inhibitory constants of the tested compounds are in the nanomolar range and are up to five orders of magnitude lower than the Michaelis constants of the synthetase enzymes. Additional modification of the ribose with a 2′-linker (see scheme) allows usage of the enzymes as matrix-bound inhibitors, which makes them suitable for future applications such as the study of enzyme mechanism, crystallization, or directed protein evolution.
No takes yet. Share an insight, caveat, or question.
Finking et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: